CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C16704 | BRD-K44925448 | BRD-K44925448 | -- | -- | -- | Details |
| C16705 | BRD-K44925462 | BRD-K44925462 | -- | -- | -- | Details |
| C16706 | BRD-K44928623 | BRD-K44928623 | -- | -- | -- | Details |
| C16707 | BRD-K44929916 | JAS07-005 | -- | -- | JAS-07-005 | Details |
| C16708 | BRD-K44931544 | BRD-K44931544 | -- | -- | -- | Details |
| C16709 | BRD-K44932450 | BRD-K44932450 | -- | -- | -- | Details |
| C16710 | BRD-K44935022 | BRD-K44935022 | -- | -- | -- | Details |
| C16711 | BRD-K44936922 | BRD-K44936922 | -- | -- | -- | Details |
| C16712 | BRD-K44937047 | BRD-K44937047 | -- | -- | -- | Details |
| C16713 | BRD-K44942188 | fomocaine | -- | -- | -- | Details |
| C16714 | BRD-K44942604 | pentolinium | -- | -- | -- | Details |
| C16715 | BRD-K44944875 | BRD-K44944875 | -- | -- | -- | Details |
| C16716 | BRD-K44946060 | BRD-K44946060 | -- | -- | -- | Details |
| C16717 | BRD-K44950949 | BRD-K44950949 | -- | -- | -- | Details |
| C16718 | BRD-K44953633 | BRD-K44953633 | -- | -- | -- | Details |
| C16719 | BRD-K44955380 | BRD-K44955380 | -- | -- | -- | Details |
| C16720 | BRD-K44956383 | BRD-K44956383 | -- | -- | -- | Details |
| C16721 | BRD-K44968548 | BRD-K44968548 | -- | -- | -- | Details |
| C16722 | BRD-K44968554 | BRD-K44968554 | -- | -- | -- | Details |
| C16723 | BRD-K44974079 | ticagrelor | P2RY12 | Purinergic receptor antagonist | -- | Details |
| C16724 | BRD-K44975377 | BRD-K44975377 | -- | -- | -- | Details |
| C16725 | BRD-K44978017 | BRD-K44978017 | -- | -- | -- | Details |
| C16726 | BRD-K44978960 | BRD-K44978960 | -- | -- | -- | Details |
| C16727 | BRD-K44980533 | BRD-K44980533 | -- | -- | -- | Details |
| C16728 | BRD-K44981211 | BRD-K44981211 | -- | -- | -- | Details |
| C16729 | BRD-K44984558 | BRD-K44984558 | -- | -- | -- | Details |
| C16730 | BRD-K44993696 | atenolol | ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C16731 | BRD-K44993940 | BRD-K44993940 | -- | -- | -- | Details |
| C16732 | BRD-K44994529 | BRD-K44994529 | -- | -- | -- | Details |
| C16733 | BRD-K44996602 | BRD-K44996602 | -- | -- | -- | Details |
| C16734 | BRD-K44999613 | BRD-K44999613 | -- | -- | -- | Details |
| C16735 | BRD-K45006718 | BRD-K45006718 | -- | -- | -- | Details |
| C16736 | BRD-K45007932 | ANLE-138B | -- | -- | -- | Details |
| C16737 | BRD-K45010872 | BRD-K45010872 | -- | -- | -- | Details |
| C16738 | BRD-K45013226 | BRD-K45013226 | -- | -- | -- | Details |
| C16739 | BRD-K45013233 | BRD-K45013233 | -- | -- | -- | Details |
| C16740 | BRD-K45022385 | BRD-K45022385 | -- | -- | -- | Details |
| C16741 | BRD-K45025380 | BRD-K45025380 | -- | -- | -- | Details |
| C16742 | BRD-K45028728 | WY-01-045 | -- | -- | -- | Details |
| C16743 | BRD-K45028867 | BRD-K45028867 | -- | -- | -- | Details |
| C16744 | BRD-K45031696 | BRD-K45031696 | -- | -- | -- | Details |
| C16745 | BRD-K45033698 | BRD-K45033698 | -- | -- | -- | Details |
| C16746 | BRD-K45033733 | famciclovir | -- | -- | -- | Details |
| C16747 | BRD-K45037973 | BRD-K45037973 | -- | -- | -- | Details |
| C16748 | BRD-K45038844 | BRD-K45038844 | -- | -- | -- | Details |
| C16749 | BRD-K45042519 | BRD-K45042519 | -- | -- | -- | Details |
| C16750 | BRD-K45043387 | BRD-K45043387 | -- | -- | -- | Details |
| C16751 | BRD-K45044525 | BRD-K45044525 | -- | -- | -- | Details |
| C16752 | BRD-K45044657 | TC-H-106 | -- | -- | -- | Details |
| C16753 | BRD-K45050268 | BRD-K45050268 | -- | -- | -- | Details |
| C16754 | BRD-K45056194 | BRD-K45056194 | -- | -- | -- | Details |
| C16755 | BRD-K45056520 | BRD-K45056520 | -- | -- | -- | Details |
| C16756 | BRD-K45057266 | BRD-K45057266 | -- | -- | -- | Details |
| C16757 | BRD-K45058172 | BRD-K45058172 | -- | -- | -- | Details |
| C16758 | BRD-K45058329 | BRD-K45058329 | -- | -- | -- | Details |
| C16759 | BRD-K45062933 | BRD-K45062933 | -- | -- | -- | Details |
| C16760 | BRD-K45068323 | W-13 | MYLK; PDE1A; CALM1 | Calmodulin antagonist | -- | Details |
| C16761 | BRD-K45071273 | tetracaine | SCN9A; SCN10A | Membrane integrity inhibitor | -- | Details |
| C16762 | BRD-K45073068 | BRD-K45073068 | -- | -- | -- | Details |
| C16763 | BRD-K45076286 | BRD-K45076286 | -- | -- | -- | Details |
| C16764 | BRD-K45077070 | BRD-K45077070 | -- | -- | -- | Details |
| C16765 | BRD-K45077605 | BRD-K45077605 | -- | -- | -- | Details |
| C16766 | BRD-K45086103 | sulfaguanidine | -- | -- | -- | Details |
| C16767 | BRD-K45090628 | BRD-K45090628 | -- | -- | -- | Details |
| C16768 | BRD-K45091989 | BRD-K45091989 | -- | -- | -- | Details |
| C16769 | BRD-K45092764 | BRD-K45092764 | -- | -- | -- | Details |
| C16770 | BRD-K45092891 | BRD-K45092891 | -- | -- | -- | Details |
| C16771 | BRD-K45095313 | BRD-K45095313 | -- | -- | -- | Details |
| C16772 | BRD-K45097650 | BRD-K45097650 | -- | -- | -- | Details |
| C16773 | BRD-K45098285 | BRD-K45098285 | -- | -- | -- | Details |
| C16774 | BRD-K45101864 | BRD-K45101864 | -- | -- | -- | Details |
| C16775 | BRD-K45112293 | BRD-K45112293 | -- | -- | -- | Details |
| C16776 | BRD-K45114207 | BRD-K45114207 | -- | -- | -- | Details |
| C16777 | BRD-K45114520 | BRD-K45114520 | -- | -- | -- | Details |
| C16778 | BRD-K45115014 | BRD-K45115014 | -- | -- | -- | Details |
| C16779 | BRD-K45117373 | Y-26763 | KCNJ8 | Potassium channel activator | -- | Details |
| C16780 | BRD-K45124535 | BRD-K45124535 | -- | -- | -- | Details |
| C16781 | BRD-K45134469 | BRD-K45134469 | -- | -- | -- | Details |
| C16782 | BRD-K45136330 | BRD-K45136330 | -- | -- | -- | Details |
| C16783 | BRD-K45138525 | BRD-K45138525 | -- | -- | -- | Details |
| C16784 | BRD-K45142472 | BRD-K45142472 | -- | -- | -- | Details |
| C16785 | BRD-K45145114 | BRD-K45145114 | -- | -- | -- | Details |
| C16786 | BRD-K45147071 | BRD-K45147071 | -- | -- | -- | Details |
| C16787 | BRD-K45149020 | amcinonide | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C16788 | BRD-K45151011 | BRD-K45151011 | -- | -- | -- | Details |
| C16789 | BRD-K45152786 | merbarone | TOP2A | Topoisomerase inhibitor | -- | Details |
| C16790 | BRD-K45153357 | BRD-K45153357 | -- | -- | -- | Details |
| C16791 | BRD-K45153693 | BRD-K45153693 | -- | -- | -- | Details |
| C16792 | BRD-K45156967 | BRD-K45156967 | -- | -- | -- | Details |
| C16793 | BRD-K45158365 | valsartan | AGTR1 | Angiotensin receptor antagonist | -- | Details |
| C16794 | BRD-K45168550 | SB-756050 | GPBAR1 | G protein-coupled receptor agonist | -- | Details |
| C16795 | BRD-K45172622 | BRD-K45172622 | -- | -- | -- | Details |
| C16796 | BRD-K45174347 | BRD-K45174347 | -- | -- | -- | Details |
| C16797 | BRD-K45177540 | BRD-K45177540 | -- | -- | -- | Details |
| C16798 | BRD-K45184415 | BRD-K45184415 | -- | -- | -- | Details |
| C16799 | BRD-K45185240 | BRD-K45185240 | -- | -- | -- | Details |
| C16800 | BRD-K45185691 | BRD-K45185691 | -- | -- | -- | Details |
| C16801 | BRD-K45190659 | BRD-K45190659 | -- | -- | -- | Details |
| C16802 | BRD-K45192137 | dexamethasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C16803 | BRD-K45200389 | BRD-K45200389 | -- | -- | -- | Details |